definiens: which is defined as [ * * * ] relating to biomarkers ( i ) that are part ofBlueprint Background Intellectual Property or ( ii ) that is generated by or on behalf of Blueprint or both Parties duringthe course of performing the Activities under the Project and Project Schedule . In addition, Blueprint shall own all [ * * * ] - 16 -Confidential and Proprietary Information of Blueprint and QIAGEN * * * Text Omitted and Filed Separately with the Securities and Exchange CommissionConfidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4 ) and 230.406 relating to the Blueprint Product that is generated by or on behalf of either Party or both Parties during the course ofperforming the Activities under the Project and Project Schedule ( the ) . QIAGEN, as far as it isin the legal position to do so, hereby assigns and agrees to assign all of its right, title and interest in and to suchBiomarker Data and Blueprint Product Data to Blueprint and if it not in a legal position to so assign, QIAGEN herebygrants and agrees to grant to Blueprint an exclusive, world - wide, irrevocable, perpetual, fully paid - up license to use theBlueprint Biomarker Data and Blueprint Product Data for any purpose . QIAGEN shall promptly provide to Blueprintcopies of or access to all Blueprint Biomarker Data and Blueprint Product Data to which QIAGEN or its Affiliates haveaccess, and all related supporting documentation, information, results and analyses with respect to QIAGEN ’s Activitiesunder a Project or Project Schedule, when and as such Blueprint Biomarker Data and Blueprint Product Data becomeavailable . Blueprint hereby grants and agrees to grant to QIAGEN a non - exclusive, world - wide, sub - licensable, non - transferable ( except as permitted under Section 18.6 ) and royalty - free license to all Blueprint Biomarker Data describedin clause ( ii ) of the first sentence of this Section 8.1(b ) for any purpose